MARATTO

article · Journal of Indian Academy of Oral Medicine and Radiology

Serum Uric Acid Level in Patients with Oral Lichen Planus. A Correlation with Disease Clinical Scores: A Case-Control Study

2025Open accessAlexandria University

Abstract

Abstract Background: Oral lichen planus (OLP) is an inflammatory disease with unclear pathogenesis. Uric acid is an antioxidant in biological fluids that has been found to be reduced in patients with this disease. Objectives: To measure the serum levels of uric acid in OLP patients and compare this with healthy controls as well as correlate those levels with clinical scores of patients. Methods: A case-control study was performed on 20 patients with OLP and 20 healthy individuals with the same age and sex. Blood samples were withdrawn from all participants, and the serum uric acid level was analyzed. For patients, pain and clinical lesion assessment was performed using the visual analog scale and Escudier et al . criteria, respectively. Results: There was no significant difference between uric acid levels in patients as compared to healthy individuals. However, significant moderate negative correlations were found between uric acid level and both OLP severity ( P = 0.001*) and activity ( P = 0.01*). Conclusions: Uric acid can be used to assess OLP patients for both lesion severity and activity. Nonetheless, further studies should be conducted to obtain more evidence about its exact role in OLP pathology.

Research topics

  • Oral Health Pathology and Treatment
  • Oral and gingival health research
  • Oral and Maxillofacial Pathology

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4103/jiaomr.jiaomr_6_25

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.